Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116449332 | 11644933 | 2 | F | 20131023 | 20160823 | 20151020 | 20160831 | PER | US-ELI_LILLY_AND_COMPANY-US201510003245 | ELI LILLY AND CO | 47.56 | YR | M | Y | 151.93000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116449332 | 11644933 | 1 | PS | AXIRON | TESTOSTERONE | 1 | Unknown | UNK, UNKNOWN | U | 22504 | ORAL LIQUID | ||||||||
| 116449332 | 11644933 | 2 | SS | TESTOSTERONE CYPIONATE. | TESTOSTERONE CYPIONATE | 1 | Unknown | UNK, MONTHLY (1/M) | U | U | 0 | /month | |||||||
| 116449332 | 11644933 | 3 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 116449332 | 11644933 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 116449332 | 11644933 | 5 | C | XARELTO | RIVAROXABAN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 116449332 | 11644933 | 6 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 116449332 | 11644933 | 7 | C | HYDROCODONE | HYDROCODONE | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116449332 | 11644933 | 1 | Blood testosterone decreased |
| 116449332 | 11644933 | 2 | Androgen replacement therapy |
| 116449332 | 11644933 | 3 | Blood pressure increased |
| 116449332 | 11644933 | 4 | Blood cholesterol increased |
| 116449332 | 11644933 | 5 | Anticoagulant therapy |
| 116449332 | 11644933 | 6 | Blood cholesterol increased |
| 116449332 | 11644933 | 7 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116449332 | 11644933 | HO |
| 116449332 | 11644933 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116449332 | 11644933 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116449332 | 11644933 | 1 | 20130705 | 20131005 | 0 | |
| 116449332 | 11644933 | 2 | 20130927 | 20131027 | 0 | |
| 116449332 | 11644933 | 3 | 2004 | 0 | ||
| 116449332 | 11644933 | 4 | 2010 | 0 | ||
| 116449332 | 11644933 | 5 | 2012 | 0 | ||
| 116449332 | 11644933 | 6 | 2010 | 0 | ||
| 116449332 | 11644933 | 7 | 2009 | 0 |